Tag: Alteogen Inc.

Alteogen Showcases ALT-B4’s Potential to Transform ADC Development at World ADC Summit 2026

Preclinical data demonstrate enhanced systemic exposure and bioavailability, reduced dermal toxicity, and improved safety profile in ALT-B4-enabled ADC therapyKey PointsSuperior PK: Subcutaneous administration of ADCs...

Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, ‘EYLUXVI® (ALT-L9)’

CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing EYLUXVI® to the reference product Eylea®Upon approval, EYLUXVI® will...

- A word from our sponsors -

HomeTagsAlteogen Inc.

ToolGen Opens Advanced Field Testing Facility in Osong, Completing ‘Bench-to-Field’ Commercialization Platform for Global SAF and Industrial Crop Markets

EVNIA Launches Three High Refresh-Rate Gaming Monitors for Japan’s Summer Promotion

SeAH Aerospace & Defense Receives Boeing’s Supplier Production Partner Award for Excellence in Aerospace Materials

Tag: Alteogen Inc.

Alteogen Showcases ALT-B4’s Potential to Transform ADC Development at World ADC Summit 2026

Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, ‘EYLUXVI® (ALT-L9)’

Explore

Press Releases

News & Opinion

Living

Others

Follow us